Connect with us
European Gaming Congress 2024

Artificial Intelligence

Global Ciprofloxacin Ophthalmic Solution Market Size Predicted to Surpass $228.92 Bn Growth by 2030, Growing at a CAGR of 5.4%

Published

on

<!– Name:DistributionId Value:8811180 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:2791 –> <!– Name:CustomerId Value:1092386 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:39ff736b-ab85-4d79-be46-5cbb5a8ee48b –>

New York, NY, April 19, 2023 (GLOBE NEWSWIRE) — Zion Market Research has published a new research report titled “Ciprofloxacin Ophthalmic Solution Market By Dosage (2 Drops/30 Minutes, 2 Drops/15 Minutes, And 1-2 Drops/2hrs), By Type (Branded And Generic), By End-Users (Hospitals, Homecare, Specialty Clinics, Others), By Application (Bacterial Conjunctivitis And Corneal Ulcers), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” in its research database.

“According to the latest research study, the demand of global Ciprofloxacin Ophthalmic Solution Market size & share in terms of revenue was valued at USD 152.24 Million in 2022 and it is expected to surpass around USD 228.92 million mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 5.4% during the forecast period 2023 to 2030.”

What is Ciprofloxacin Ophthalmic Solution? How big is the Ciprofloxacin Ophthalmic Solution Industry?

Ciprofloxacin Ophthalmic Solution Report Coverage & Overview:

Advertisement
Stake.com

The ciprofloxacin ophthalmic solution industry refers to the production and distribution of eye solutions or eye drops that contain the antibiotic drug ciprofloxacin which is a type of fluoroquinolone antibiotic. It is used to treat bacterial eye infections such as keratitis, conjunctivitis, and corneal ulcers. The industry is led by many factors but also struggles with various growth limitations and challenges. During the forecast period, the industry is expected to come across multiple regulatory concerns as governments across the globe are becoming stricter in terms of medicinal goods circulated in the market.

Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs – https://www.zionmarketresearch.com/sample/ciprofloxacin-ophthalmic-solution-market

(A free sample of this report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the Following:

  • Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.
  • The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
  • About 218+ Pages Research Report (Including Recent Research)
  • Provide detailed chapter-by-chapter guidance on Request
  • Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023
  • Includes Tables and figures have been updated
  • The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
  • Zion Market Research research methodology

(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)

Global Ciprofloxacin Ophthalmic Solution Market: Growth Dynamics

Advertisement
Stake.com

The global ciprofloxacin ophthalmic solution market is expected to grow owing to the rising rate of infections, such as corneal ulcers and bacterial conjunctivitis. As the solution is highly effective in managing these conditions, the growing number of patients is likely to impact the demand for ciprofloxacin ophthalmic solution. In addition to this, the increasing awareness surrounding eye care and eye medications may work in the favor of the industry. The rising awareness rate is driven by extensive initiatives undertaken by the government and non-government healthcare-related agencies to educate the masses about the importance of eye care and measures to adopt in case of infections.

The rising investments toward overall healthcare infrastructure may play a crucial role during the forecast period since this is directly translated to more people having access to basic or advanced eye care. As the healthcare community is witnessing a surge in demand for self-administered medications, the demand for ciprofloxacin ophthalmic solution may also grow rapidly.

The global ciprofloxacin ophthalmic solution industry is expected to deal with several growth restraints. One of the major impacting points is the rising strictness of the regional healthcare authorities toward the medicinal products that are imported from foreign countries, as many countries have recently reported certain medicines to be leading causes of additional medical conditions even translating to death in certain cases. In addition to this, factors like frequent patent expiration and associated side effects may also impede industry growth. As healthcare policies across the globe are registering a steady shift, reimbursement policies may also be affected thus causing reduced demand for the solution.

The growing investment toward advancement in drug delivery technologies may provide growth opportunities while the growing competition from generic medicines could challenge market expansion.

Directly Purchase a copy of the report with TOC @ https://www.zionmarketresearch.com/buynow/su/ciprofloxacin-ophthalmic-solution-market

Advertisement
Stake.com

Report Scope

Report Attribute Details
Market Size in 2022 USD 152.24 Million
Projected Market Size in 2030 USD 228.92 Million
CAGR Growth Rate 5.4% CAGR
Base Year 2022
Forecast Years 2023-2030
Key Market Players Jubilant Life Sciences Limited, Novartis AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Lupin Limited, Allergan plc, Zydus Cadila Healthcare Ltd., Bausch Health Companies Inc., Fresenius Kabi AG, Akorn, Inc, Paragon BioTeck, Inc., Sandoz International GmbH, Cipla Inc., Santen Pharmaceutical Co., Ltd., Senju Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Mylan N.V., Hikma Pharmaceuticals PLC, Valeant Pharmaceuticals International, Inc., Alcon Inc., Micro Labs Limited, Apotex Inc., Shire plc, Ophthotech Corporation, and Kowa Company, Ltd.
Key Segment By Type, By Application, and By Region
Major Regions Covered North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa
Purchase Options Request customized purchase options to meet your research needs. Explore purchase options

Ciprofloxacin Ophthalmic Solution Market: Segmentation Analysis

The global ciprofloxacin ophthalmic solution market is segmented based on dosage, type, end-users, application, and region.

Based on dosage, the global market segments are 2 drops/30 minutes, 2 drops/15 minutes, and 1-2 drops/2hrs. In 2022,

Based on type, the global market segments are branded and generic. The industry registered the highest growth in the generic segment in 2022 since it is more affordable and more readily available as compared to branded versions. However, it should be noted that generic medicines can only be manufactured once the patent of the branded medicines has expired. Also, some patients or professionals may prefer to use branded medicines. On average, patent terms can last up to 20 years from the date of filing, but they may vary depending on several external factors.

Advertisement
Stake.com

Based on end-users, the ciprofloxacin ophthalmic solution industry segments are hospitals, homecare, specialty clinics, and others.

Based on application the global market divisions are bacterial conjunctivitis and corneal ulcers. During the forecast period, bacterial conjunctivitis is expected to lead with the highest CAGR since it is a relatively common condition as compared to corneal ulcers. It can affect people from all age groups. The condition is also called pink eye and results from bacterial infection of the conjunctiva. Although corneal infections are less common, they are deemed more serious since it arises due to injury to the cornea. Hence the condition may require the use of the solution along with other antibiotics. Bacterial conjunctivitis generally resolves within 1 to 2 weeks.

The global Ciprofloxacin Ophthalmic Solution market is segmented as follows:

By Dosage

  • 2 Drops/30 minutes
  • 2 Drops/15 minutes
  • 1-2 Drops/2hrs

By Type

  • Branded
  • Generic

By End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Application

  • Bacterial Conjunctivitis
  • Corneal Ulcers

Browse the full “Ciprofloxacin Ophthalmic Solution Market By Dosage (2 Drops/30 Minutes, 2 Drops/15 Minutes, And 1-2 Drops/2hrs), By Type (Branded And Generic), By End-Users (Hospitals, Homecare, Specialty Clinics, Others), By Application (Bacterial Conjunctivitis And Corneal Ulcers), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” Report at https://www.zionmarketresearch.com/report/ciprofloxacin-ophthalmic-solution-market

Competitive Landscape

Advertisement
Stake.com

Some of the main competitors dominating the global Ciprofloxacin Ophthalmic Solution market include – 

  • Jubilant Life Sciences Limited
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Lupin Limited
  • Allergan plc
  • Zydus Cadila Healthcare Ltd.
  • Bausch Health Companies Inc.
  • Fresenius Kabi AG
  • Akorn Inc
  • Paragon BioTeck Inc.
  • Sandoz International GmbH
  • Cipla Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Senju Pharmaceutical Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Hikma Pharmaceuticals PLC
  • Valeant Pharmaceuticals International Inc.
  • Alcon Inc.
  • Micro Labs Limited
  • Apotex Inc.
  • Shire plc
  • Ophthotech Corporation
  • Kowa Company Ltd.

Key Insights from Primary Research:

  • According to the analysis shared by our research forecaster, the Ciprofloxacin Ophthalmic Solution market is likely to expand at a CAGR of around 5.4% during the forecast period (2023-2030).            
  • In terms of revenue, the Ciprofloxacin Ophthalmic Solution market size was valued at around US$ 152.24 Million in 2022 and is projected to reach US$ 228.92 million by 2030. The market is projected to grow at a significant rate due to the growing prevalence of eye infections
  • Based on dosage segmentation, 1-2 drops/2hrs was predicted to show maximum market share in the year 2022
  • Based on end-user segmentation, hospitals were the leading users in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Have Any Query? Ask Our Experts: https://www.zionmarketresearch.com/inquiry/ciprofloxacin-ophthalmic-solution-market

Key questions answered in this report:

  • What is the market size and growth rate forecast for Ciprofloxacin Ophthalmic Solution industry?
  • What are the main driving factors propelling the Ciprofloxacin Ophthalmic Solution Market forward?
  • What are the leading companies in the Ciprofloxacin Ophthalmic Solution Industry?
  • What segments does the Ciprofloxacin Ophthalmic Solution Market cover?
  • How can I receive a free copy of the Ciprofloxacin Ophthalmic Solution Market sample report and company profiles?

Key Offerings:

  • Market Size & Forecast by Revenue | 2023−2030
  • Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
  • Market Segmentation – A detailed analysis By Dosage, By Type, By End-Users, By Application, And By Region
  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Request for Customization on this Report as per your requirements – https://www.zionmarketresearch.com/custom/7147

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

Regional Analysis:

The global ciprofloxacin ophthalmic solution market is expected to grow with the highest CAGR in North America mainly due to the growing aging population in these areas. The elderly population is highly vulnerable to bacterial eye infections. Furthermore, the already existing large number of users of the ciprofloxacin ophthalmic solution may contribute significantly to the regional market. North America is known to have high healthcare expenditure per capita which may also lead to increased use of the solution.

Advertisement
Stake.com

In Asia-Pacific, the growth may be driven by the robust pharmaceutical sectors of India and China. The former is one of the leading exporters of a variety of medication for its neighboring countries as well as western territories. Furthermore, the generally densely populated areas of these countries lead to higher chances of spreading contagious diseases which is another factor for the region’s high demand for eye care solutions.

By Region

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • France
    • UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • The Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Recent Developments

  • In March 2023, Paul Karpecki, the director of the cornea and external disease at the Kentucky Eye Institute, initiated the Innovation Showcase of the Ophthalmic Innovation Summit (OIS) which was held at SECO 2023. The presentations at the summit included topics like volume-reducing adaptors for dropper bottles and gene therapy for neurotrophic keratitis (NK)
  • In February 2020, Chennai, an Indian city, registered a high influx of patients suffering from ‘Madras Eyes’. Childcare specialists named the condition pharyngoconjunctival fever.

To know an additional revised 2023 list of market players, request a brochure of the report: https://www.zionmarketresearch.com/requestbrochure/ciprofloxacin-ophthalmic-solution-market

FREQUENTLY ASKED QUESTIONS

  • What is the ciprofloxacin ophthalmic solution?
  • Which key factors will influence ciprofloxacin ophthalmic solution market growth over 2023-2030?
  • What will be the value of the ciprofloxacin ophthalmic solution market during 2023-2030?
  • What will be the CAGR value of the ciprofloxacin ophthalmic solution market during 2023-2030?
  • Which region will contribute notably towards the ciprofloxacin ophthalmic solution market value?
  • Which are the major players leveraging the ciprofloxacin ophthalmic solution market growth?

Browse Other Related Research Reports from Zion Market Research:

Advanced Functional Materials Market By Type (Ceramics, Energy Materials, Conductive Polymers, Nanomaterials, Composites, And Others), By End-User Industry (Electrical & Electronics, Automotive, Healthcare, Aerospace & Defense, Energy & Power, And Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/advanced-functional-materials-market

Autoinjector Market: Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2022-2028: https://www.zionmarketresearch.com/report/autoinjector-market

Advertisement
Stake.com

Antihyperlipidemic Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2022-2028: https://www.zionmarketresearch.com/report/antihyperlipidemic-drugs-market

Pharmaceutical Solvents Market: Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2020-2026: https://www.zionmarketresearch.com/report/pharmaceutical-solvents-market

Postnatal Health Supplements Market: Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2020-2026: https://www.zionmarketresearch.com/report/postnatal-health-supplements-market

Influenza Vaccine Market: Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2020-2026: https://www.zionmarketresearch.com/report/influenza-vaccine-market

Ultrasonic Cleaning Equipment Market: Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2020-2026: https://www.zionmarketresearch.com/report/ultrasonic-cleaning-equipment-market

Advertisement
Stake.com

Medical Grade Silicone Market: Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2020-2026: https://www.zionmarketresearch.com/report/medical-grade-silicone-market

Artificial Heart Market: Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2020-2026: https://www.zionmarketresearch.com/report/artificial-heart-market

Psychotropic Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2020-2026: https://www.zionmarketresearch.com/report/psychotropic-drugs-market

About Zion Market Research:

Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Advertisement
Stake.com

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/

Follow Us on Twitter: https://twitter.com/zion_research

Follow Us on Facebook: https://www.facebook.com/zionmarketresearch

Follow Us on Pinterest: https://www.pinterest.com/zionmarketresearch/

Advertisement
Stake.com

Follow Us on YouTube: https://youtu.be/Y0Yfi7N8zSs

Contact Us:

Rushikesh Dorge

USA: +1 347 690-0211

United Kingdom: +44 2032 894158

Advertisement
Stake.com

Japan: +81 50 5806 9039

India: +91 7768 006 007

Web: https://www.zionmarketresearch.com/

Blog: https://zmrblog.com/

Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?

Advertisement
Stake.com

Email Directly Here with Detail Information: [email protected]

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Actian Launches Zen 16.0, the Next Generation Database for Edge Computing

Published

on

actian-launches-zen-16.0,-the-next-generation-database-for-edge-computing

Latest Zen Edition Delivers Secure, Modular, and Scalable Edge Data Solutions with Seamless Synchronization from Edge to Cloud
ROUND ROCK, Texas, June 17, 2024 /PRNewswire/ — Actian, the data and analytics division of HCLSoftware, today announced the launch of Actian Zen 16.0, the newest version of its innovative embedded database. To help businesses run faster, smarter applications on the edge, Zen 16.0 is designed for real-time data processing across mobile, IoT devices, edge gateways, and complex machinery.

Actian developed Zen 16.0 to capture the growing demand for edge computing. IDC predicts edge computing will account for $232 billion in spending this year*. Zen 16.0 simplifies and optimizes edge computing for resource-constrained environments that range from industrial IoT and connected healthcare to smart cities. Actian Zen 16.0 introduces performance enhancements and new features designed to improve efficiency and functionality for the more than 13,000 organizations currently using Zen, as well as attracting new customers.
“Actian Zen16.0 is designed to meet the needs of modern embedded systems and edge computing,” said Emma McGrattan, senior vice president of engineering and product at Actian. “Its secure and scalable design allows for easy data synchronization with Zero-ETL, making it perfect for developers creating intelligent applications that can deliver real-time decisioning from edge to cloud to give a business competitive advantage.”
Zen 16.0 delivers the small footprint with fast read and write access and automatic administration that resource-constrained environments require. Zen16.0 addresses the need to support high-performance intelligent applications with minimal administration, particularly for frequent data update use cases like sensor data collection to monitor patient well-being or asset management tracking using RFID scanners.
Zen 16.0 ensures seamless data synchronization from edge to cloud, supports both SQL and NoSQL data access, and leverages popular programming languages to empower developers in building low-latency embedded applications.
“Actian Zen provides a high performance, lightweight, and self-managed embedded database for our business,” said Trent Maynard, Director of Product & Engineering at Global Shop Solutions. “Zen continues to deliver exactly what we need and we’re enthusiastic about the new capabilities of Zen 16.0 to empower our business operations even further.” 
Detailed here, Zen 16.0 includes improved L2 cache sizing, page preload for large data files, Kafka data stream support, EasySync – a new datasync utility, enhanced JSON support, Btrieve2 Python package, Docker and Kubernetes container support, and extended index key length.
*Source: IDC Press Release, New IDC Spending Guide Forecasts Edge Computing Investments Will Reach $232 Billion in 2024, March 2024
About Actian
Actian makes data easy. We deliver cloud, hybrid, and on-premises data solutions that simplify how people connect, manage and analyze data. We transform business by enabling customers to make confident, data-driven decisions that accelerate their organization’s growth. Our data platform integrates seamlessly, performs reliably, and delivers industry-leading speeds at an affordable cost. Actian is a division of HCLSoftware.
Media Contacts
Danielle LeeSenior Director – Global Analyst Relations & Public [email protected]
Ali WheelerPublic Relations [email protected]
Logo – https://mma.prnewswire.com/media/2429927/Actian_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/actian-launches-zen-16-0–the-next-generation-database-for-edge-computing-302173606.html

Continue Reading

Artificial Intelligence

Application Security Market worth $55.0 billion by 2029- Exclusive Report by MarketsandMarkets™

Published

on

application-security-market-worth-$55.0-billion-by-2029-exclusive-report-by-marketsandmarkets™

CHICAGO, June 17, 2024 /PRNewswire/ — The global Application Security Market to grow from USD 33.7 billion in 2024 to USD 55.0 billion by 2029 at a compound annual growth rate (CAGR) of 10.3% during the forecast period, according to a new report by MarketsandMarkets™. The application security (AppSec) market is expanding rapidly due to the growing reliance on applications and the escalating threat of cyberattacks. The increasing frequency and sophistication of these attacks are driving the demand for strong AppSec solutions, a trend likely to persist. As organizations shift to cloud-based applications, new security challenges arise, requiring AppSec solutions that can adapt and provide robust controls. AppSec vendors are creating user-friendly tools that integrate smoothly with developer workflows, promoting an early vulnerability detection approach. Small and medium-sized enterprises (SMEs) and organizations with limited security resources are turning to Managed Security Service Providers (MSSPs) for affordable expertise and tools. The extensive use of open-source software (OSS) also presents unique security issues, leading to the evolution of AppSec solutions to effectively secure open-source code.

Browse in-depth TOC on “Application Security Market”
200 – Tables 50 – Figures350 – Pages
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=110170194
Scope of the Report
Report Metrics
Details
Market size available for years
2018–2029
Base year considered
2023
Forecast period
2024–2029
Forecast units
Value (USD Billion)
Segments Covered
By Type, By Component, By Organization Size, By Deployment mode, By Vertical, and By Region
Geographies covered
North America, Europe, Asia Pacific, Middle East Africa, and Latin America
Major companies covered
Major vendors in the global Application Security Market include IBM (US), HCL (India), Synopsys (US), Microfocus (UK), Capgemini (France), Onapsis (US), Cloudflare (US), Guardsquare (Belgium), Checkmarx (US), Fortinet (US), Checkpoint (Israel), Broadcom (US), Palo Alto Networks (US), Qualys (US), Rapid7 (US)
By Component, the services segment will grow at the highest CAGR during the forecast period.
The cybersecurity skills gap persists as a significant challenge, but AppSec services offer a solution by providing access to experienced security professionals who can design, implement, and manage effective application security programs. These services bring specialized expertise in areas like penetration testing, security code reviews, and vulnerability assessments, complementing standard solutions and addressing complex security challenges. Navigating data privacy regulations and industry-specific security standards can be daunting, but AppSec services provide compliance guidance, helping organizations efficiently meet regulatory requirements. Managed Security Service Providers (MSSPs) play a crucial role in the AppSec services market, offering comprehensive security solutions such as AppSec assessments, vulnerability management, and ongoing monitoring, which is cost-effective and beneficial for organizations with limited security resources. AppSec services are also evolving to integrate seamlessly with DevSecOps workflows, allowing security professionals to collaborate with developers in identifying and addressing vulnerabilities early in the development lifecycle. Moreover, these services increasingly include security awareness training programs to educate employees on recognizing and mitigating security threats, complementing technical controls with essential human vigilance.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=110170194
By Type, the Mobile Application Security segment will grow at a higher CAGR during the forecast period.
The mobile application security segment within the broader application security (AppSec) market is experiencing rapid growth due to the widespread use of smartphones and the proliferation of mobile apps. With an ever-increasing number of mobile applications across diverse industries, ensuring their security has become a paramount concern. The trend of Bring Your Own Device (BYOD) further complicates security efforts, as personal devices may lack the same level of security controls as corporate-issued ones. Mobile AppSec solutions must address these concerns while complying with data privacy regulations governing the collection and storage of sensitive user data. Integrating security throughout the mobile app development lifecycle is crucial, with solutions tailored to seamlessly integrate with developer workflows to promote early vulnerability detection and remediation. Mobile AppSec solutions need to cater to the specific security requirements of both iOS and Android platforms, each with its own vulnerabilities and testing methodologies. Techniques like app shielding and code obfuscation are also being employed to deter attackers from reverse engineering and exploiting vulnerabilities within mobile applications.
Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=110170194
By region, Asia Pacific will grow at the highest CAGR during the forecast period.
The Asia Pacific region is undergoing significant growth in its Application Security Market, driven by several key factors. As industries undergo rapid digital transformation, there’s a heightened need for robust security measures to protect interconnected systems. Moreover, the region faces increasing cyber threats, prompting businesses to prioritize application security as a crucial defense mechanism. Stricter data privacy regulations, akin to data protection laws in Europe, mandate strong security practices for handling personal data, further driving market demand. Cloud adoption is surging, leading to a need for cloud-native security solutions that effectively protect applications in cloud environments. Managed Security Service Providers are becoming popular, especially among SMEs, offering cost-effective access to security expertise. Additionally, the adoption of agile and DevOps methodologies necessitates application security solutions that seamlessly integrate with development workflows. Despite challenges such as low awareness of security best practices, skills shortages, and budget constraints, the long-term outlook for the Asia Pacific Application Security Market remains highly positive. Factors like digitalization, cyber threats, and data privacy regulations are expected to sustain market growth, alongside trends like cloud computing and managed security services adoption.
Top Key Companies in Application Security Market:
Major vendors in the global Application Security Market include IBM (US), HCL (India), Synopsys (US), Microfocus (UK), Capgemini (France), Onapsis (US), Cloudflare (US), Guardsquare (Belgium), Checkmarx (US), Fortinet (US), Checkpoint (Israel), Broadcom (US), Palo Alto Networks (US), Qualys (US), Rapid7 (US).
Browse Adjacent Market: Information Security Market Research Reports & Consulting
Browse Other Reports:
Secure Multiparty Computation Market – Global Forecast to 2029
Managed Detection and Response Market – Global Forecast to 2029
Exposure Management Market- Global Forecast to 2029
Workplace Safety Market- Global Forecast to 2028
IDaaS Market- Global Forecast to 2028
Get access to the latest updates on Application Security Companies and Application Security Industry
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Aashish MehraMarketsandMarkets™ INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [email protected] Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/application-security-market-worth-55-0-billion-by-2029–exclusive-report-by-marketsandmarkets-302172900.html

Continue Reading

Artificial Intelligence

Membrane Chromatography Market to Reach USD 637 Million with 14.7% CAGR | MarketsandMarkets™

Published

on

membrane-chromatography-market-to-reach-usd-637-million-with-14.7%-cagr-|-marketsandmarkets™

CHICAGO, June 17, 2024 /PRNewswire/ — The membrane chromatography market is poised to grow significantly, with a projected value of USD 637 million by 2029, reflecting a robust CAGR of 14.7% from an estimated USD 321 million in 2024. This growth is primarily fueled by the escalating production of biopharmaceuticals like vaccines and monoclonal antibodies, coupled with increased R&D activities in the biopharmaceutical sector. Key players in this market include Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), and Thermo Fisher Scientific Inc. (US), who employ strategies such as new product launches, acquisitions, agreements, collaborations, and geographical expansions to bolster their market presence. Danaher Corporation is known for its extensive range of life science and diagnostic products, investing heavily in R&D, while Sartorius AG stands out for its global reach and strategic collaborations like the one with Waters Corporation for downstream biomanufacturing. Merck KGaA, on the other hand, is recognized for its comprehensive solutions and ongoing investments in R&D, as demonstrated by its substantial investment in membrane and filtration manufacturing capabilities in Cork, Ireland.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151487196
Browse in-depth TOC on “Membrane Chromatography Market”416 – Tables52 – Figures348 – Pages
DRIVER: Catalyzing Growth Through Increased Biopharmaceutical R&D
As C-level executives, you’re aware of the pivotal role R&D plays in the biopharmaceutical sector, especially amidst the escalating demand for treatments targeting chronic illnesses. The robust increase in R&D investments, exemplified by a significant uptick in spending among Spanish biotech firms in 2022, underscores the driving force behind the membrane chromatography market’s expansion.
RESTRAINT: Slow Adoption in Large-Scale Manufacturing
Despite its promising advantages, membrane chromatography encounters obstacles when it comes to scaling up for large-scale operations. Challenges such as membrane degradation and fouling, coupled with the entrenched dominance of traditional column chromatography, impede widespread adoption. These complexities, alongside the risks of process disruption and quality compromises, restrain the market’s growth within large-scale manufacturing.
OPPORTUNITY: Embracing Single-Use Technologies for Enhanced Efficiency
The shift towards single-use membrane chromatography systems presents a compelling opportunity for executives seeking efficiency gains. These systems offer tangible benefits, including reduced contamination risks and lower capital investments. Collaborative efforts, like the partnership between W. L. Gore & Associates, Inc. and AGC Biologics, signal a strategic move towards streamlining downstream purification processes and maximizing productivity.
CHALLENGE: Competing with Alternative Techniques
In the landscape of membrane chromatography, executives must navigate the challenge posed by alternative techniques such as protein crystallization and capillary electrophoresis. These methods, renowned for their simplicity and cost-effectiveness, present formidable competition, potentially diverting market focus from membrane chromatography solutions and posing a significant hurdle to its sustained growth.
Global Membrane Chromatography Industry Ecosystem Analysis
Executives operating within the membrane chromatography industry are part of a multifaceted ecosystem encompassing raw material suppliers, manufacturers, and end users ranging from pharmaceutical giants to academic institutions. Product portfolios span from essential syringe filters to advanced membrane sheets, catering to diverse needs across the sector’s spectrum.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=151487196
Flow-Through Membrane Chromatography Leads Industry Growth in 2023
The dominance of flow-through membrane chromatography in 2023 underscores a strategic focus on biologics development, particularly monoclonal antibodies. The segment’s ascendancy is further fueled by the industry’s quest for efficient chromatography operations, positioning it as a key driver in the membrane chromatography market.
Pharmaceutical & Biopharmaceutical Companies Drive Market Growth
In 2023, pharmaceutical and biopharmaceutical companies emerged as the dominant force within the membrane chromatography landscape, buoyed by the escalating demand for biotherapeutics. The segment’s robust growth trajectory is propelled by increased R&D investments aimed at advancing biopharmaceutical products, solidifying its pivotal role in the membrane chromatography market.
North America Commands Membrane Chromatography Market in 2023
North America’s commanding presence in the membrane chromatography market during 2023 underscores its status as a key hub for biopharmaceutical development and manufacturing. With significant investments in R&D and a well-established healthcare sector, North America leads the global market, followed closely by Europe and the Asia Pacific, reflecting the region’s pivotal role in driving industry innovation and growth.
Recent Innovations Shape Membrane Chromatography Landscape
Thermo Fisher Scientific Inc. Enhances Presence in Asia Pacific with New FacilityIn February 2024, Thermo Fisher Scientific Inc. fortified its position in the Asia Pacific market with the inauguration of a sterile drug facility in Singapore. This strategic investment aligns with the company’s commitment to delivering new medicines and vaccines, complementing enhanced research capabilities at its Customer Experience Center and Bioprocess Design Center. The Customer Experience Center, equipped with a wide array of products spanning molecular biology, genetic analysis sequencing, chromatography mass spectrometry, and cell therapy, underscores Thermo Fisher Scientific’s dedication to innovation and customer-centric solutions.Agilent Technologies Invests in Nucleic Acid Therapeutics ManufacturingJanuary 2023 witnessed Agilent Technologies’ significant investment of USD 725 million to expand its manufacturing capacity for nucleic acid-based therapeutics. This expansion underscores Agilent’s commitment to meeting the growing demand for advanced therapeutics, positioning the company as a key player in the evolving landscape of nucleic acid-based treatments.Sartorius AG Expands Portfolio Through Novasep AcquisitionIn February 2022, Sartorius AG bolstered its chromatography capabilities with the acquisition of Novasep’s chromatography division. This strategic move enables Sartorius to access a portfolio tailored for smaller biomolecules like oligonucleotides, peptides, and insulin, as well as innovative systems for continuous biologics manufacturing. By integrating Novasep’s offerings, Sartorius aims to diversify its revenue streams and strengthen its position as a leading provider of chromatography solutions.3M Introduces Breakthrough Solution for Protein Therapeutic ManufacturingJune 2021 marked the launch of 3M Harvest RC clarifier, a revolutionary single-stage purification solution designed for recombinant protein therapeutic manufacturing. This innovation underscores 3M’s commitment to advancing bioprocessing technologies, offering a streamlined and efficient solution for protein purification, thereby enhancing manufacturing efficiency and product quality.For more information, inquire now! Inquire Now
Related Reports:
Chromatography Instruments Market
Chromatography Accessories & Consumables Market
High Performance Liquid Chromatography Market
Gas Chromatography Market
Life Science Instrumentation Market
Get access to the latest updates on Membrane Chromatography Companies and Membrane Chromatography Market Share
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Aashish MehraMarketsandMarkets™ INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [email protected] Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/membrane-chromatography-market-to-reach-usd-637-million-with-14-7-cagr–marketsandmarkets-302172920.html

Continue Reading

Trending